Chul Ahn

3 articles listing Chul Ahn in Nature Communications, Science Advances, indexed by Paperzzz from Crossref and OSF.

1. Domvanalimab plus zimberelimab in unresectable and immunotherapy refractory biliary tract cancers: a phase 2 trial Nature Communications
2. Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in KRAS -mutant non–small cell lung cancer Science Advances
3. Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trial Nature Communications